Celestia S. Higano
0000-0001-5308-8972
Publication & Citation Trends
Most Cited Works
Publications
692 total
Real-world characteristics of long-term survivors with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): An analysis of the global REASSURE study.
Cited by 0
Semantic Scholar
Long-term outcomes with radium-223 in metastatic castration resistant prostate cancer: US patient subset of the 10-year REASSURE global study.
Cited by 0
Semantic Scholar
Comparing virtual and in-person training for intracavernosal injection therapy in a multidisciplinary sexual health clinic within a prostate cancer survivorship program.
Cited by 2
Semantic Scholar
Relationship between androgen deprivation therapy and kidney function in patients with prostate cancer: An analysis of the RADICAL-PC study.
Cited by 0
Semantic Scholar
Prostate Cancer Supportive Care (PCSC) program: An alternative to consolidated framework for implementation research (CFIR) model.
Cited by 0
Semantic Scholar
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes OA
Cited by 10
Semantic Scholar
Comparing patient profiles and treatment outcomes with radium-223 (223Ra) in real-world settings: Academic vs. community practice in the US—Insights from the REASSURE study.
Cited by 0
Semantic Scholar
Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer OA
Cited by 6
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(487)
Radiopharmaceutical Chemistry and Applications
(174)
Prostate Cancer Diagnosis and Treatment
(108)
Cancer, Lipids, and Metabolism
(74)
Cancer Immunotherapy and Biomarkers
(71)
Frequent Co-Authors
Affiliations
Université Paris-Sud
AstraZeneca (United Kingdom)
Northwestern University
Ontario Institute for Cancer Research
Seattle Pacific University